vaxon-biotech.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title vaxon-biotech
Description Home About Technology Research & Development News & Events NEWS – EVENTS To contact VAXON Biotech from June, 15th 2018: info@vaxon-biotech.com or 07.66.03
Keywords N/A
Server Information
WebSite vaxon-biotech faviconvaxon-biotech.com
Host IP 185.105.30.34
Location -
Related Websites
Site Rank
More to Explore
vaxon-biotech.com Valuation
US$776,142
Last updated: 2022-06-29 09:43:22

vaxon-biotech.com has Semrush global rank of 13,637,079. vaxon-biotech.com has an estimated worth of US$ 776,142, based on its estimated Ads revenue. vaxon-biotech.com receives approximately 89,555 unique visitors each day. Its web server is located in -, with IP address 185.105.30.34. According to SiteAdvisor, vaxon-biotech.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$776,142
Daily Ads Revenue US$717
Monthly Ads Revenue US$21,494
Yearly Ads Revenue US$257,918
Daily Unique Visitors 5,971
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
vaxon-biotech.com. A 1799 IP: 185.105.30.34
vaxon-biotech.com. NS 1800 NS Record: ns3.hixcore.com.
vaxon-biotech.com. NS 1800 NS Record: ns1.hixcore.com.
vaxon-biotech.com. NS 1800 NS Record: ns2.hixcore.com.
vaxon-biotech.com. MX 1800 MX Record: 5 mail.ixserver.net.
HtmlToTextCheckTime:2022-06-29 09:43:22
Home About Technology Research & Development News & Events NEWS – EVENTS To contact VAXON Biotech from June, 15th 2018: info@vaxon-biotech.com or 07.66.03.05.55 June 1st, 2017 – Vaxon announces results of its Phase IIb lung cancer trial of Vx-001, a therapeutic vaccine based on optimized cryptic peptides Results for non-small-cell lung cancer patients show that survival more than doubled in a subgroup of never- and light-smokers versus placebo – Vx-001 could also have wider application in cancers where immune checkpoint inhibitors alone are inefficient Press release to download – Version Française VAXON Biotech develops innovative immuno-therapeutic products to treat cancer VAXON Biotech is a private company, located in Paris – France, that was founded in 2004. The company develops innovative therapeutic vaccines for the treatment of cancers including lung, gastric, prostate, breast, renal, liver and colorectal cancers, using its proprietary technology of optimized cryptic peptides .
HTTP Headers
HTTP/1.1 200 OK
Date: Tue, 26 Oct 2021 16:01:21 GMT
Server: Apache
content-type: text/html; charset=UTF-8
x-powered-by: PHP/5.3
x-pingback: http://vaxon-biotech.com/xmlrpc.php
link: ; rel="https://api.w.org/", ; rel=shortlink
x-iplb-request-id: B9691E22:871E_D5BA2103:0050_61782651_EB49:2B09F
x-iplb-instance: 28278
Vary: Accept-Encoding
vaxon-biotech.com Whois Information
Domain Name: VAXON-BIOTECH.COM
Registry Domain ID: 111504241_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.gandi.net
Registrar URL: http://www.gandi.net
Updated Date: 2020-11-13T14:53:32Z
Creation Date: 2004-02-09T09:31:14Z
Registry Expiry Date: 2022-02-09T09:31:14Z
Registrar: Gandi SAS
Registrar IANA ID: 81
Registrar Abuse Contact Email: abuse@support.gandi.net
Registrar Abuse Contact Phone: +33.170377661
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS1.HIXCORE.COM
Name Server: NS3.HIXCORE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-14T15:49:27Z <<<